. Author manuscript; available in PMC: 2014 Jan 24.

Published in final edited form as: Cancer Chemother Pharmacol. 2009 Feb 17;64(4):803–810. doi: 10.1007/s00280-009-0931-y

Table 5.

Anti-tumor Activity

Patient ID	Dose Level	Tumor Type	Response	TTP (wks)
3	1	Melanoma^*	PR	15
24	8	Head/Neck	PR	22
28	10	Melanoma	PR	11
43	1A	Head/Neck	PR	10

Prior cisplatin treatment